OccamzRazor (Series A)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Artificial Intelligence and Robotics
Valuation
$45,000,000
Company Info
Founders
Katharina Sophia Volz
Market
Information Technology
Coinvestors
Jeff Dean,Dreamers Fund,Techammer,Phil Libin
Company Description

Using machine learning to develop curative therapies for previously incurable neurocognitive diseases. OccamzRazor is a combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development.